Rationale: Myocardial infarction is a leading cause of death in developed nations, and there remains a need for cardiac therapeutic systems that mitigate tissue damage. Cardiac progenitor cells (CPCs) and other stem cell types are attractive candidates for treatment of myocardial infarction; however, the benefit of these cells may be as a result of paracrine effects.
C ardiovascular disease is the leading cause of morbidity and mortality in developed nations, and acute myocardial infarction (MI) is a major contributor to poor outcomes, particularly in the United States and other developed nations. 1 Beyond the acute treatment of restoring blood flow to hypoxic myocardium, subsequent measures focus on improving the contractility of noninfarcted tissue. Typically, the damaged, relatively nonregenerative myocardium undergoes a degenerative remodeling process that leads to heart failure. Furthermore, the economic burden of cardiovascular disease is profound. In 2010, costs for cardiovascular disease-related care totaled $315.4 billion, and by 2030, costs are expected to grow to $918 billion when 43.9% of the population is expected to have cardiovascular disease. 1
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Cell-based therapies to treat the damaged heart-including injection of stem cells from various sources-have yielded mixed results in several species. [2] [3] [4] Cardiac progenitor cells (CPCs), a small population of stem-like cells residing in the heart, are of interest as they differentiate into cardiac lineages and can be isolated by tissue biopsy. Induced differentiation of stem cells into various cardiac cell types has shown changes in cell exocytosis in response to different growth conditions. [5] [6] [7] However, whether these changes in stem cell exocytosis have a beneficial effect on the cardiac response through differentiation or paracrine signaling is unknown. January 16, 2015
MicroRNAs (miRNAs) are recognized as important regulators of intracellular gene expression. Recently, they have been discovered extracellularly in the blood of mammals. 8 Since then, stable extracellular miRNAs have also been identified in urine, saliva, semen, breast milk, and cerebrospinal fluid. 8 Furthermore, distinct miRNA profiles in biofluids have been linked to disease pathologies, leading to interest in the use of extracellular miR-NAs as disease biomarkers. [9] [10] [11] Extracellular miRNA profiles have already been explored for a range of conditions, including cancer, diabetes mellitus, and cardiovascular diseases. 10, 12, 13 Extracellular miRNAs are protected from degradation by nucleases because they are encapsulated within membrane-derived vesicles (apoptotic bodies, microvesicles, and exosomes) or they form complexes with extracellular proteins. 8, 12, 14, 15 Recent efforts have been made to explore the endogenous function of circulating miRNAs, especially in intercellular communication and gene regulation. 8, 16 Interestingly, the miRNA signatures are unique among different carriers 14 and between carriers and parent cells, suggesting regulated export of miRNAs. 14, 17, 18 Exosomes are secreted membrane-bound vesicles, with diameters ranging from 30 to 130 nm that carry a multitude of signals. Most cells secrete exosomes; those verified include platelets, 12 lymphocytes, 16 and adipocytes 19 and muscle, 10,20 tumor, 21 glial, 22 and stem cells. [23] [24] [25] In this report, we isolated exosomes from the media of CPCs exposed to hypoxic and normoxic conditions for 3 or 12 hours, and we examined the effects of these exosomes on cardiac cells in vitro and in vivo. We also analyzed exosomal miRNA via array and identified several miRNAs upregulated in response to hypoxia. Using empirical data and statistical transformation processes, we developed a computational model that predicts the effects of hypoxia and normoxia on the miRNA content of exosomes produced by CPCs. Finally, we identified covarying miR-NA clusters that may lead to future bio-inspired therapeutics.
Methods

Cardiac Progenitor Cell Isolation
CPCs were isolated from neonatal adult Sprague-Dawley rats by removing the heart and homogenizing the tissue as described. 3
Exosome Generation
CPCs were grown to 90% confluence and quiesced for 12 hours. Plated cells were subjected to normoxic or hypoxic conditions for 3 or 12 hours. To generate hypoxic conditions, cells were transferred to an incubator chamber (Billups-Rothenberg MIC-101) and flushed with hypoxic gas mixture (95% N 2 and 5% CO 2 ). After conditioning, the media was subjected to sequential centrifugation (Optima XPN-100 ultracentrifuge; Beckman Coulter SW 41 Ti rotor) at 10 000g for 35 minutes to remove cell debris and 100 000g for 70 minutes followed by 2 washings in PBS (100 000g for 70 minutes). The exosome pellet was isolated and the protein content of the exosome suspension was analyzed by Micro BCA Protein Assay kit (Thermo Scientific Pierce 23235) according to the manufacturer's instructions.
Secreted miRNA Analysis
miRNA was isolated from conditioned media with the miRVANA PARIS kit (Invitrogen AM1556M) according to the manufacturer's protocol. The miRNA solutions were analyzed (Agilent 2100 Bioanalyzer) for size, quality, and quantity of miRNA. After characterization, miRNA was subjected to analysis via Affymetrix MultiSpecies MicroRNA GeneChip array. Data were analyzed in Affymetrix Expression Console to determine levels of miRNA upregulation.
To evaluate levels of upregulated miRNA in exosomes, exosomal miRNA was isolated with the miRVANA PARIS kit and cDNA generated via NCode miRNA First-Strand cDNA Synthesis Kit (Invitrogen MIRC-50) according to the manufacturer's protocol. cDNA samples were then subjected to qRT-PCR and relative mRNA levels ascertained by comparative CT method, with RNU6B as the housekeeping gene. The mean minimal cycle threshold values were calculated from triplicate reactions.
Principle Component and Partial Least Squares Regression Analysis
Principle component (PC) and partial least squares regression analysis were performed as described previously, 26, 27 using the SIMCA-P software (UMetrics) that solves the partial least squares regression (PLSR) problem with the nonlinear iterative partial least squares algorithm. 28 An expanded Methods section is available in the Online Data Supplement.
Results
Verification of Exosome Internalization
Exosomes were isolated and characterized as described in Online Figure I. To determine whether cardiac cell types of interest could internalize exosomes derived from CPCs subjected to 12 hours of hypoxia or normoxia, cardiac endothelial cells and fibroblasts were incubated for 12 hours with Acridine Orange or calcein-labeled exosomes and imaged by confocal microscopy ( Figure 1A and 1E) or ImageStream flow cytometry ( Figure 1B and 1F). Internalization of exosomes was confirmed visually by the presence of intracellular punctate fluorescence and also confocally by localization of exosomes in the same plane as nuclei in z-stacks. Analysis of number of spots per cell revealed no difference in uptake between exosomes from hypoxic or normoxic CPCs in either cell type ( Figure 1C and 1G). Furthermore, similar findings were observed for average fluorescence intensity per cell ( Figure 1D and 1H). We also examined uptake of exosomes derived from CPCs subjected to 3 hours of hypoxia or normoxia and saw similar trends (Online Figure IIA -IIF). Uptake by primary rat cardiomyocytes was minimal (Online Figure IIG ).
Exosomes From Hypoxic CPCs Increase Tube Formation
To determine functional effects of exosomes on endothelial cells, we evaluated whether exosome internalization could induce endothelial tube formation. Cardiac endothelial cells were treated for 24 hours with exosomes from hypoxic or normoxic CPCs and then plated on Geltrex before imaging ( Figure 2A ). Treatment group tube lengths were normalized to tube formation measured in nontreated cells. Although exosomes from normoxic CPCs had no significant effect on tube formation, exosomes from hypoxic CPCs significantly enhanced formation of tube-like structures ( Figure 2B ). This response was dependent on exosome dose, and disruption of exosomes from hypoxic CPCs via sonication abrogated the effect. Furthermore, cotreatment with the RNA-induced silencing complex inhibitor Nonstandard Abbreviations and Acronyms CPC cardiac progenitor cells CTGF connective tissue growth factor MI myocardial infarction TGF transforming growth factor aurintricarboxilic acid 29 negated the effects of exosomes on tube formation. We also examined angiogenic gene expression in endothelial cells treated with exosomes and found modest changes in response to either exosome treatment (Online Figure III) .
Exosomes From Hypoxic CPCs Reduce Profibrotic Genes
To investigate the potential effects of exosomes on fibrotic gene expression, we treated rat cardiac fibroblasts with either exosomes derived from 12 hours normoxic or hypoxic CPCs before stimulation with TGF-β. TGF-β stimulation significantly increased connective tissue growth factor (CTGF), collagen I (COLI), collagen III (COLIII), and vimentin (VIM) gene expression ( Figure 3 ). We observed no significant decrease in CTGF, COLI, COLIII, or VIM levels after treatment with exosomes from 12 hours normoxic CPCs, but detected a significant decrease of CTGF (43%), COLIII (56%), and VIM (44%) mRNAs in cells treated with 12 hours hypoxic exosomes compared with TGF-β stimulation alone. COLI was decreased 42% by 12 hours hypoxic exosomes, but this was not considered statistically significant.
CPC miRNA Secretome Is Altered in Response to Hypoxia
We isolated the small RNA fraction of CPC-conditioned media (3 and 12 hours normoxia and hypoxia) and performed Affymetrix GeneChip miRNA array. For the 12-hours time point, 11 miR-NAs were upregulated ≥2-fold in response to hypoxic conditions. qRT-PCR analysis of small RNA isolated from pooled exosomes validated the upregulation 7 of the 11 miRNAs by hypoxia ( Figure 4A , light bars). Interestingly, 6 of the 7 miRNA upregulated in hypoxic exosomes have been previously shown to have a role in cardiac function (Online Figure IV) . Only 2 of these miRNAs were upregulated in microvesicles (miR-17 and -210). We also examined donor CPC miRNA levels after 12 hours of normoxia or hypoxia. We observed an inverse relationship between donor intracellular ( Figure 4A , dark bars) and exosomal miRNA levels. To determine miRNA transfer, we measured the intracellular levels of 3 upregulated miRNAs in recipient endothelial cells and fibroblasts ( Figure 4B and 4C) and we observed a 2.1-fold increase of miR-292 in fibroblasts from treatment with 12 hours hypoxic exosomes. Although not statistically significant, the trend suggests that 12 hours hypoxic exosomes increased miR-103 and -15b in endothelial cells.
Lack of Effect From 3 Hour Exosomes
We measured transfer of miRNA in recipient endothelial cells and fibroblasts treated with 3 hours exosomes ( Figure 5A and 5B). In contrast to 12 hours exosomes, we found no significant increase of any of the examined miRNAs in recipient cells.
Based on earlier models, exosomes generated in 3 hours of hypoxia or normoxia were not projected to be a potent driver of fibrotic mRNA expression or tube formation. Out of the 4 fibrotic mRNAs examined ( Figure 5C -5F), only COLI decreased significantly (64%) when treated with 3 hours hypoxic exosomes ( Figure 5D ). No significant effect on tube formation was observed in cells treated with 3 hours exosomes ( Figure 5G ).
Principle Component Analysis Reveals Covarying miRNA Clusters
We used principle component analysis of the microarray data to investigate covarying relationships among the miRNAs that were up-or downregulated after pretreatment conditions. The There was no effect of exosome treatment on connective tissue growth factor (CTGF; C), collagen III (COLIII; E), or vimentin (VIM, F) expression. Exosomes generated in 3 h did not influence tube formation (G); there was no significant increase with either exosome type. ANOVA followed by Tukey post-test. Mean±SEM, *P<0.05.
first PC separated the fold change differences from the absolute values of the miRNA levels, as expected. PC 2 and 3 were far more interesting in that 4 distinct clusters of covarying miRNAs were identified as shown in Figure 6A .
To assign biological activity to each of these clusters, we used the miRNAs from the microarray that were validated by qRT-PCR ( Figure 6A ) as landmarks on the PC plot. miR-20a, miR-199a-5p, and miR-292-5p covary with the green cluster, miR-292-3p with the blue cluster, and miR-17 and miR-103 with the red cluster, and miR-17, miR-210, miR-15b, and miR-20a cluster with responses that are a combination of both the red and blue clusters.
Partial Least Square Regression Linked miRNA Clusters to Physiological Responses
PLSR was used to establish a relationship between the cue (preconditioning hypoxia/normoxia and time duration) and the signal (miRNA levels), which were then mapped onto a putative biological response in an unbiased approach (cue-signal-response paradigm). PLSR models were made using the entire 377 miRNAs from the microarray matched to the responses of tube formation and mRNA expression of CTGF, COLI, COLIII, and VIM as measured above, but then a reduced model was made with just the 11 miRNAs confirmed by miRNA array that were matched to physiologically relevant outcomes for angiogenesis and fibrosis. Scores plot shows that each treatment is separated across a PC with each time/treatment combination in a different quadrant ( Figure 6B ).
Separation across PC 1 (x-axis) indicates time difference as 3 and 12 hours timepoints are on opposite sides, and PC 2 (y-axis) separates the cues by oxygen treatment. In the loadings plot to the right in Figure 6B , CTGF and tube formation responses were segregated over PC 2 (oxygen treatment). Covarying miRNAs are shown as well on the loadings plot in PC space.
Refined PLSR Models Retained Integrity
Predictability of our model using a bootstrapping approach was determined for responses of tube formation and mRNA expression of CTGF, COLI, COLIII, and VIM. PLSR also determines the most important miRNA signals contributing to that response by calculating the variable importance for projection. The 211 miRNAs with variable importance for projection values ≥1 were chosen in an unbiased manner, and their model's predictability was compared with the full model of all 377 miRNAs and against the 11 select miRNA model. The model trained only with significant variable importance for projections had the best predictability of 99%. However, the model with only the 11 miRNAs still maintained a 96.8% predictability ( Figure 6C) , slightly above the 96.5% of the full set of 377 miRNAs. This finding indicates that these 11 miRNAs may provide sufficient data to predict a biological response after exosome treatment or even that manipulating their relative levels may be sufficient to drive that particular biological response of CTGF expression or tube formation. 
Unbiased Identification of Additional miRNAs That Significantly Contribute to Angiogenic and Antifibrotic Responses but not Identified by Microarray
To identify other miRNAs that may contribute to these responses, beyond the initial 11 chosen based on fold-change in the microarray, miRNA weighted coefficients of significant magnitude were investigated for being toward or against the physiological responses of CTGF and tube formation. Of these, 33 unique miRNAs were pro-tube formation (positive weighted coefficient) and 21 were anti-CTGF (negative-weighted coefficient) with 17 miRNAs fitting this category for both responses ( Figure 7A) . The list is shown in Figure 7B . Plotting only these miRNAs in PC space illustrates clustering with angiogenic response of tube formation and are antifibrotic, in that they are opposite CTGF mRNA expression ( Figure 7C ).
Hypoxic Exosomes Improve Function in the Infarcted Heart
We measured fractional shortening of the left ventricle 7 and 21 days after ischemia-reperfusion injury ( Figure 8A and 8B) . Ischemia-reperfusion significantly reduced function at both time points, but only treatment with 12 hour exosomes significantly improved function: in the acute phase (increased from 30.6% to 36.4%) and chronic phase (increased from 27.6% to 34.2%). We also measured fibrosis in reconstructed whole heart sections. Only treatment with 12 hours exosomes significantly reduced fibrosis ( Figure 8C and 8D ).
Discussion
Stem cell-based therapies to treat detrimental myocardial remodeling and cardiac dysfunction post-MI have shown promise, but significant obstacles to this approach remain. If possible, the amplification and delivery of beneficial paracrine signals generated by these cells could overcome obstacles associated with cell injection-based approaches to repair damaged myocardium. 10, 30 Because CPCs are specialized to function in the heart, CPC-generated signals may be particularly well suited to treat cardiac pathologies. Very few studies have investigated the therapeutic potential of CPC exosomes. In one, exosomes enhanced endothelial migration, indicating angiogenic effects. 25 CPC exosomes were also shown to reduce myoblast apoptosis in vitro and decrease myocyte cell death in an animal MI model. 23 However, in both of these studies, exosomes were generated under normoxic conditions, which likely did not reflect the state of postinfarct tissue. Importantly, hypoxic preconditioning enhanced the benefit of CPC therapy in an animal MI model. 31 Here, exosomes generated by CPCs grown under normoxic conditions had a diminished reparative capacity compared with exosomes from hypoxic cells. This difference in physiological response was not caused by vesicle size, total RNA content, or protein levels because these values were similar between the different exosome groups. We found punctate (≈1 μm) fluorescence in recipient cells treated by the different groups of exosomes, suggesting that exosomes deposit their cargo through endocytic pathways, which is then transported to the perinuclear region by the cytoskeleton. 10,20 Figure 7 . Partial least squares regression (PLSR) analysis identifies additional miRNAs from exosomes that covary with angiogenic (tube formation) and antifibrotic (anti-CTGF [connective tissue growth factor]) responses. Weighted coefficients of miRNAs determined to have significant variable importance for projection (VIP) values were investigated for their projections toward or against responses of CTGF and tube formation to identify other miRs beyond the initial 11 chosen based on fold change in the microarray. A, Venn diagram indicating that 33 unique miRs were protube formation and 21 miRs were anti-CTGF, with 17 miRs projecting toward both responses. B, List of miRs associating with only protube formation, against CTGF, or both responses. C, Loadings plot of these 37 miRs with responses showing weighted coefficients and clustering of miRs identified through unbiased PLSR analysis.
We found that hypoxic exosomes induced tube formation, but the effect leveled off after 0.1 μg/mL. Disruption of exosomes by means of sonication abrogated the effect of hypoxic exosomes on tube formation, indicating the need for intact exosomes for induction of the physiological effect. Furthermore, RNA-induced silencing complex inhibition attenuated the angiogenic effects of hypoxic exosomes, strongly suggesting that exosomal miRNAs were responsible for changes in the physiological effects. Importantly, hypoxia increased the levels of proangiogenic miR-17 32 and -210 33, 34 in exosomes. We were unable to detect any major changes in a panel of angiogenic genes studied after treatment with exosomes from hypoxic (12 hours) CPCs. Although there were some changes in other groups, these were small (<1.4-fold) and did not lead to increased tube formation. It could be possible that exosome treatment alters other processes involved in angiogenesis, such as endothelial cell proliferation, migration, and survival.
Post-MI, the proliferation of fibroblasts leads to the formation of noncontractile scar tissue, 35 which, when combined with the extensive cardiomyocyte death, 10 leads to long-term systolic dysfunction. In the damaged heart, fibroblasts are stimulated by cytokines, such as TGF-β, which leads to an increase in production of CTGF, 36 exacerbation of extracellular matrix production, 37 and enhanced fibrosis. 38 We found that exosomes from hypoxic CPCs decreased levels of CTGF, VIM, and COLI and COLIII, whereas there was no effect of exosomes from normoxic CPCs. The beneficial effects of hypoxia-derived CPC exosomes could be as a result of the increased levels of miR-17, 39 -199a, 40 -210, 34 and -292, 40 all of which have been either demonstrated to target or predicted to target genes involved in the fibrosis pathway. Specifically, miR-17 has been shown to regulate CTGF levels. 39, 41 We did examine cardiomyocytes in this study, but no functional benefit was seen after treatment with any exosome group (Online Figure V) .
We used microarray analysis to examine temporally dynamic extracellular miRNA release from CPCs after 3 and 12 hours of hypoxia. Of the 11 miRNAs upregulated by ≥2-fold by hypoxia at the 12-hour time point, qRT-PCR confirmed that 7 were encapsulated by exosomes. Interestingly, most of these have been shown to be involved in regulating cardiac functions of interest. One of the hypoxia-generated miRNAs, miR-15b, has been shown to be upregulated in the circulation of patients with critical limb ischemia. 42 Here, we focused on miRNAs encapsulated within exosomes, although miRNAs may be transported extracellularly by other modalities, namely microparticles, proteins, and lipoproteins, which were not evaluated in this study. 8, 12, 14, 15 Indeed, we did detect 2 miRNAs upregulated in microparticles, and these also may have beneficial effects. Additionally, exosomes carry other molecules, including proteins, phospholipids, and carbohydrates. Although our data suggest exosomal miRNA played a critical role in the physiological response of recipient cells, we do not rule out the contribution of other exosomal cargo.
Computational modeling tools have been instrumental in evaluating large biological data sets, so they were well-suited to handle our wide array of dynamic exosomal content. We measured 377 mature miRNAs at both the 3-and 12-hour time points that may be difficult to attribute to specific functions. The cue-signal-response paradigm was able to extract important biological information by integrating known and unknown measurable variables. This powerful computational tool has been used to better understand data sets and develop predictive models in a variety of biological systems. 26, 27 The use of this paradigm was particularly important for miRNAs because 1 miRNA may affect hundreds of genes. miRNAs that changed covariantly will result in them clustering through principle component analysis. Indeed, principle component analysis on the normalized data from our microarray analysis identified miRNAs clusters that covary based on treatment condition. We were surprised to find that the majority of miRNAs clearly grouped into 4 major clusters. The black cluster is pro-hypoxic and blue is the opposite. Red and green clusters do not respond to hypoxia (zero projection onto PC2, the hypoxia axis), but are the effects caused by another currently unknown mechanism.
In the PLSR model trained with only the 11 miRNAs from the array, miR-292 had a high variable importance for projection scoring, indicating a potentially influential role in the responses. To date, there are no reports of miR-292 as a regulator of cardiac function, and studies are underway to determine the role of this miRNA in the cardiovascular system. Since the functions of miR-20a and -17 have been described, other miRNAs closely clustering and covarying with these 2 may have similar roles in modulating cardiac function and repair. Overall, PLSR modeling is a helpful method to prioritize testing of new miR-NAs that may be involved in certain biological outcomes. For example, if further analysis verifies an important role for miR-292 in improving cardiac function, then inclusion of other miR-NAs from its cluster could amplify its protective effects. Indeed miR-292 was identified, unbiased, in the new group of miR-NAs based on their weighted coefficients ( Figure 7B ), along with 36 others that might be beneficial to amplify the effect of tube formation although minimizing the profibrotic response. We initially examined only the miRNA that were upregulated >2-fold with RT-PCR, but the model was able to consider all Only treatment with 12 h hypoxic exosomes significantly reduced fibrosis (E). Mean±SEM, n=4 to 7, ANOVA followed by Tukey post test. ###P<0.001 compared with sham group, *P<0.05, **P<0.01. January 16, 2015 miRNA within the array. There were several pre-miRNA that were also increased, although none over 2-fold. Additionally, we did not examine the miRNA that were decreased in hypoxic exosomes. This is difficult to address because even if the miR-NA are decreased in hypoxic-derived exosomes, they will still be transferred (albeit at a smaller level) to recipient cells. They could potentially explain why normoxic exosomes were less effective (a decrease in hypoxic-derived exosomes would mean they are enriched in normoxic-derived exosomes). We saw that exosomes from hypoxic CPCs had decreased levels of miR-320 (shown to be antiangiogenic), 43, 44 miR-222 (proapoptotic and antimigration), 45 and miR-185 (profibrotic). 46 The lack of these signals in hypoxic-derived exosomes and the enrichment of proregenerative miRNA could be an interesting area for future studies, and these types of modeling algorithms can provide information on potential biological effect.
Many of these 37 identified in Figure 7B were not identified by high-fold change in the microarray, providing a greater rationale for using multivariate analytical methods that consider the miRNA levels changing in response to a cue, but having an effect on several biological responses, instead of solely focusing on the miRNA signal changing as the final outcome. By mapping the signal changes to different biological responses (here CTGF, tube formation, COLI and COLIII, and VIM mRNA), the projection or contribution of that signal to several responses can be predicted, and their contributions to different aspects of a complex biological response may be parsed or integrated, providing insight into the same decisions cells must make.
Finally, delivery of exosomes derived from CPCs subjected to 12 hours of hypoxia improved both acute and chronic function, although inhibiting fibrosis. These data are in agreement with both our in vitro studies and our computational model. Recently, several studies have demonstrated that exosomes derived from stem cells cultured under normoxic conditions also have beneficial effects postinfarction. Although one study used cardiosphere-derived cells, 47 the other used CPCs similar to this study. 48 One major difference is that the authors used total extracellular vesicles and not exosomes alone, thus it is unclear whether the other studies would see a benefit from subjecting those cells to hypoxia. What is interesting is that those studies, as well as the one presented here, demonstrate that vesicular transfer of miR-NA is likely driving the protective/regenerative process.
In this report, we show that CPCs release a beneficial paracrine signal in response to hypoxia. We confirmed that exosomal miRNAs content is dynamically regulated based on the length of time CPCs are exposed to hypoxia. Based on our data, we developed a computational model to determine how exosome-generating conditions, miRNAs, and physiological responses covary. Together, our findings support the development of hypoxic CPC-derived exosomes as naturally derived therapeutics and lay the groundwork for statistical models that direct bio-inspired therapeutics of rational design.
What Is Known?
• Stem cell therapy for myocardial infarction (MI) has provided mixed results, with beneficial paracrine signaling being a common explanation. • A small population of cardiac progenitor cells (CPCs) resides in the heart, although the full understanding of these cells' function has yet to be fully elucidated. • Ultimately, the body is unable to fully repair the heart post-MI, leading to significant long-term ailments.
What New Information Does This Article Contribute?
• CPCs secrete exosomes in response to hypoxic conditions that benefit cardiac cells and reduce deleterious effects in the post-MI heart. • miR-15b, -17, -20a, -103, -199a, -210, and -292 are upregulated in exosomes generated in hypoxic conditions, which contribute to cardiac repair. • Systems biology analysis correlates exosomal microRNA levels to CPC stimulation and physiological responses, which provides impetus and guidance for biologically inspired therapeutics.
CPCs are attractive candidates for treatment, and it is believed that a potential mechanism is paracrine signaling. The therapeutic potential and cargo of exosomes generated in conditions that mimic MI, such as hypoxia, are unknown. We found that CPC exosomes are internalized by cardiac fibroblasts and endothelial cells and subsequently regulate their function. These exosomes also decreased cardiac fibrosis in a rat MI model and improved cardiac function in the acute and chronic phases. We found 7 microRNAs to be upregulated in exosomes generated under hypoxia and identified clusters of covarying microRNAs through systems biology analysis. This article demonstrates that CPCs tailor the contents of secreted exosomes in response to oxygen content toward a regenerative phenotype. This article is the first to show a beneficial effect of exosomes derived under hypoxic conditions, as well as model the correlation of time and oxygen levels with covarying microRNAs and physiological responses. These findings suggest that the paracrine effect of CPCs may be enhanced by hypoxia and could be a potential mechanism of cell therapy in vivo. Furthermore, systems biology analysis can be used to determine potential microRNA mediators for future investigation.
Novelty and Significance
